Document is current

Any future updates will be listed below

ASO Author Reflections: Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Surgical Conversion in Borderline Resectable Cholangiocarcinoma

Crossref DOI link: https://doi.org/10.1245/s10434-025-18076-0

Published Online: 2025-08-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark